Hospital
Burnett Medical Center INC
Burnett Medical Center INC was paid $3.21M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoBURNETT MEDICAL CENTER INC
GRANTSBURG, WI 54840
GRANTSBURG, WI 54840
33aNPI1225191687assigned 12/18/2006
33bProvider typeCritical Access Hospital
28Total paid$3.21M
24GClaims45,254
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#29 of 48
Median peer was paid$4.30M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,587 | $250K | |
| 2019 | 4,739 | $287K | |
| 2020 | 5,494 | $412K | |
| 2021 | 6,812 | $667K | |
| 2022 | 6,558 | $584K | |
| 2023 | 6,351 | $531K | |
| 2024incomplete | 9,713 | $477K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 3,854 | 3,060 | $931K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 2,481 | 1,803 | $678K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 2,012 | 1,410 | $560K |
| 96361 | Intravenous infusion, hydration; each additional hour | 14% | 649 | 442 | $437K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 1,089 | 902 | $136K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.8% | 572 | 486 | $121K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.7% | 1,189 | 1,045 | $85K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.2% | 423 | 363 | $40K |
| 80053 | Comprehensive metabolic panel | 1.2% | 4,353 | 3,278 | $38K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,324 | 3,922 | $27K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 935 | 784 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,277 | 1,049 | $15K |
38 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,056 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 33 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 538 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 491 | $9K |
| 87631 | <1% | 97 | $8K | |
| 81001 | <1% | 3,085 | $7K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 16 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 237 | $6K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 16 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 116 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,797 | $4K |
| 84484 | <1% | 617 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 305 | $3K |
| 80305 | <1% | 187 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 453 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 143 | $2K |
| 83735 | <1% | 648 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 374 | $2K |
| 85610 | <1% | 735 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 886 | $974.33 |
| 83690 | <1% | 203 | $852.31 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 13 | $818.03 |
| 87088 | <1% | 199 | $791.40 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 44 | $688.52 |
| 83605 | <1% | 85 | $572.40 | |
| 83880 | <1% | 50 | $567.98 | |
| 81025 | <1% | 43 | $424.28 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 43 | $311.55 |
| 86140 | <1% | 64 | $144.45 | |
| 82150 | <1% | 30 | $127.30 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 473 | $20.53 |
| 36416 | <1% | 34 | $10.98 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 852 | $10.02 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 883 | $8.83 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 20 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 101 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 114 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFAUGHT, CHARLES (CFO)